✦ LIBER ✦

Genetic imbalances in primary breat tumors and proliferative breast diseases

✍ Scribed by M. Varella-Garcia; R. Moreland; L. MacGavran

Book ID: 114136726
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 137 KB
Volume: 98
Category: Article
ISSN: 0165-4608
DOI: 10.1016/s0165-4608(97)90314-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of Primary Tumor Extirpation in B

Effect of Primary Tumor Extirpation in Breast Cancer Patients Who Present With Stage IV Disease and an Intact Primary Tumor

✍ Gildy V. Babiera; Roshni Rao; Lei Feng; Funda Meric-Bernstam; Henry M. Kuerer; S 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 112 KB

Comparative Genomic Hybridization Reveal

Comparative Genomic Hybridization Reveals Complex Genetic Changes in Primary Breast Cancer Tumors and Their Cell Lines

✍ Marcelo L Larramendy; Tamara Lushnikova; Anna-Maria Björkqvist; Ignacio I Wistub 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 220 KB

Genetic and epigenetic alterations in se

Genetic and epigenetic alterations in sentinel lymph nodes metastatic lesions compared to their corresponding primary breast tumors

✍ Luciane R. Cavalli; Cı&#x0301;cero A. Urban; Dongqiu Dai; Sônia de Assis; De 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 285 KB

Genetic variation and circulating levels

Genetic variation and circulating levels of IGF-I and IGFBP-3 in relation to risk of proliferative benign breast disease

✍ Xuefen Su; Graham A. Colditz; Walter C. Willett; Laura C. Collins; Stuart J. Sch 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 157 KB 👁 2 views

## Abstract Insulin‐like growth factor‐I (IGF‐I) and its major binding protein IGFBP‐3 have been implicated in breast carcinogenesis. We examined the associations between genetic variants and circulating levels of IGF‐I and IGFBP‐3 with proliferative benign breast disease (BBD), a marker of increas

The relationship between aromatase in pr

The relationship between aromatase in primary breast tumors and response to treatment with aromatase inhibitors in advanced disease

✍ Paul Chr de Jong; Marinus A Blankenstein; Johannes W.R Nortier; Peter H.Th.J Sle 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 167 KB

[Recent Results in Cancer Research] Mini

[Recent Results in Cancer Research] Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer Volume 195 || CTCs in Primary Breast Cancer (I)

✍ Ignatiadis, Michail; Sotiriou, Christos; Pantel, Klaus 📂 Article 📅 2012 🏛 Springer Berlin Heidelberg 🌐 German ⚖ 221 KB

This important book provides up-to-date information on a series of topical issues relating to the approach to minimal residual disease in breast cancer patients. It first explains how the study of minimal residual disease and circulating and disseminated tumor cells (CTCs/DTCs) can assist in the und